Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock

Procter & Gamble (PG) is a trending stock with shares down 4.3% over the past month, underperforming the S&P 500 and its industry. While earnings estimates are projected to grow modestly (2.1% for the current quarter and 2.9% for the current fiscal year), revenue growth is expected to be minimal (1.5% for the current quarter and 0.2% for the current fiscal year), and the stock is currently rated a Zacks Rank #4 (Sell), suggesting potential near-term underperformance.

Analysis

Procter & Gamble (PG) has recently underperformed, with its shares declining 4.3% over the past month, contrasting with a 0.6% gain for the Zacks S&P 500 composite and a 3.1% loss for the Zacks Consumer Products - Staples industry. While sell-side analysts project modest earnings growth, with current quarter EPS expected at $1.43 (a 2.1% year-over-year increase) and current fiscal year EPS at $6.78 (a 2.9% increase), these estimates have seen minimal upward revisions of +0.2% and +0.1% respectively over the last 30 days. Revenue growth forecasts are similarly subdued, with a projected 1.5% year-over-year increase for the current quarter to $20.85 billion, and a mere 0.2% rise for the current fiscal year to $84.24 billion. The company's last reported quarterly revenue of $19.78 billion marked a 2.1% year-over-year decrease and missed the Zacks Consensus Estimate by 2.75%, although EPS of $1.54 was in line with expectations. Over the past four quarters, P&G has surpassed consensus EPS estimates thrice but revenue estimates only once. Compounding these concerns, P&G holds a Zacks Rank #4 (Sell), suggesting potential near-term market underperformance, and its valuation is considered premium, evidenced by a Zacks Value Style Score of D. The overall sentiment surrounding the stock is moderately negative, with a cautious tone.

Key Decisions for Investors

• Given the Zacks Rank #4 (Sell), recent share price underperformance, and tepid revenue growth outlook, investors should exercise caution regarding near-term prospects for Procter & Gamble.
• The stock's premium valuation, indicated by a D grade on the Zacks Value Style Score, warrants careful consideration, especially in light of its struggles to consistently beat revenue expectations.
• Investors should closely monitor upcoming earnings reports for signs of accelerating revenue growth and margin improvement before considering new or adding to existing positions, as continued sluggishness could further pressure shares.